Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | REPL |
---|---|---|
09:32 ET | 7581 | 8.19 |
09:34 ET | 1131 | 8.24 |
09:36 ET | 1113 | 8.205 |
09:39 ET | 300 | 8.21 |
09:41 ET | 600 | 8.22 |
09:43 ET | 300 | 8.19 |
09:45 ET | 1374 | 8.11 |
09:48 ET | 16143 | 8.14 |
09:50 ET | 19297 | 8.07 |
09:52 ET | 1687 | 8.09 |
09:54 ET | 644 | 8.002 |
09:56 ET | 2348 | 7.99 |
09:57 ET | 2040 | 7.9999 |
09:59 ET | 2767 | 8.08 |
10:01 ET | 618 | 8.08 |
10:03 ET | 19643 | 8.09 |
10:06 ET | 1400 | 8.09 |
10:08 ET | 5961 | 8.06 |
10:10 ET | 2018 | 8.06 |
10:12 ET | 700 | 8.075 |
10:14 ET | 1017 | 8.08 |
10:15 ET | 32876 | 8.27 |
10:17 ET | 5936 | 8.26 |
10:19 ET | 2267 | 8.265 |
10:21 ET | 5544 | 8.2 |
10:24 ET | 2811 | 8.165 |
10:26 ET | 100 | 8.165 |
10:28 ET | 751 | 8.15 |
10:30 ET | 4894 | 8.145 |
10:32 ET | 1994 | 8.11 |
10:33 ET | 1435 | 8.1 |
10:35 ET | 4116 | 8.135 |
10:37 ET | 800 | 8.09 |
10:39 ET | 3300 | 8.085 |
10:42 ET | 1025 | 8.07 |
10:44 ET | 400 | 8.085 |
10:46 ET | 1032 | 8.055 |
10:48 ET | 500 | 8.055 |
10:50 ET | 100 | 8.06 |
10:51 ET | 6426 | 8.125 |
10:53 ET | 7116 | 8.145 |
10:55 ET | 3789 | 8.12 |
10:57 ET | 2627 | 8.07 |
11:00 ET | 900 | 8.1 |
11:02 ET | 4883 | 8.11 |
11:04 ET | 4633 | 8.0884 |
11:06 ET | 400 | 8.09 |
11:08 ET | 1880 | 8.04 |
11:09 ET | 2501 | 8.06 |
11:11 ET | 1000 | 8.06 |
11:13 ET | 1580 | 8.06 |
11:15 ET | 882 | 8.07 |
11:18 ET | 1212 | 8.07 |
11:20 ET | 2046 | 8.08 |
11:22 ET | 1573 | 8.07 |
11:24 ET | 700 | 8.06 |
11:26 ET | 500 | 8.07 |
11:27 ET | 2300 | 8.09 |
11:29 ET | 200 | 8.09 |
11:31 ET | 1200 | 8.07 |
11:33 ET | 494 | 8.08 |
11:36 ET | 1650 | 8.11 |
11:38 ET | 8300 | 8.065 |
11:40 ET | 1000 | 8.055 |
11:42 ET | 1400 | 8.055 |
11:44 ET | 594 | 8.055 |
11:45 ET | 1700 | 8.06 |
11:47 ET | 1152 | 8.09 |
11:49 ET | 1621 | 8.095 |
11:51 ET | 200 | 8.09 |
11:54 ET | 1025 | 8.06 |
11:56 ET | 1100 | 8.03 |
11:58 ET | 2086 | 8.05 |
12:00 ET | 900 | 8.05 |
12:02 ET | 100 | 8.05 |
12:03 ET | 1248 | 8.08 |
12:05 ET | 2163 | 8.09 |
12:07 ET | 1824 | 8.1 |
12:09 ET | 6396 | 8.1 |
12:12 ET | 1357 | 8.09 |
12:14 ET | 1679 | 8.0978 |
12:16 ET | 1782 | 8.1 |
12:18 ET | 3467 | 8.08 |
12:20 ET | 886 | 8.08 |
12:21 ET | 945 | 8.08 |
12:23 ET | 8095 | 8.1 |
12:25 ET | 6215 | 8.09 |
12:27 ET | 1109 | 8.035 |
12:30 ET | 5082 | 8.06 |
12:32 ET | 500 | 8.07 |
12:34 ET | 2961 | 8.1 |
12:36 ET | 2619 | 8.09 |
12:38 ET | 3208 | 8.07 |
12:39 ET | 500 | 8.06 |
12:41 ET | 2702 | 8.05 |
12:43 ET | 2724 | 8.045 |
12:45 ET | 2682 | 8.08 |
12:48 ET | 14052 | 8.07 |
12:50 ET | 1725 | 8.06 |
12:52 ET | 14021 | 8.09 |
12:54 ET | 15570 | 8.1 |
12:56 ET | 9458 | 8.09 |
12:57 ET | 6018 | 8.1 |
12:59 ET | 23227 | 8.09 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Replimune Group Inc | 542.7M | -2.5x | --- |
PepGen Inc | 540.7M | -5.1x | --- |
Corbus Pharmaceuticals Holdings Inc | 530.7M | -7.1x | --- |
Erasca Inc | 518.8M | -2.6x | --- |
PureTech Health PLC | 546.0M | -9.8x | --- |
Cassava Sciences Inc | 516.7M | -9.2x | --- |
Replimune Group, Inc. a clinical-stage biotechnology company engaged in the development of a novel class of oncolytic immunotherapies. The Company’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. RP1 (vusolimogene oderparepvec) is its lead product candidate and is based on a proprietary strain of herpes simplex virus engineered and genetically armed with a fusogenic protein (GALV-GP R-) and GM-CSF intended to maximize tumor killing potency, the immunogenicity of tumor cell death, and the activation of a systemic anti-tumor immune response. It is also developing additional product candidates, RP2 and RP3, to enhance anti-tumor immune responses and are intended to address additional tumor types, including traditionally less immune responsive tumor types. RP2 additionally expresses an anti-CTLA-4 antibody-like molecule, as well as GALV-GP R- and GM-CSF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $542.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 67.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.25 |
EPS | $-3.24 |
Book Value | $6.10 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.